Caladrius Biosciences, Inc. (NASDAQ:CLBS) has a beta value of 1.47 and has seen 1,386,053 shares traded in the recent trading session. The company, currently valued at $36.24 Million, closed the recent trade at $2.35 per share which meant it gained $0.1 on the day or 7.87% during that session. The CLBS stock price is -54.89% off its 52-week high price of $3.64 and 55.32% above the 52-week low of $1.05. If we look at the company’s 10-day average daily trading volume, we find that it stood at 716.77 Million shares traded. The 3-month trading volume is 502.97 Million shares.

The consensus among analysts is that Caladrius Biosciences, Inc. (CLBS) is an Overweight stock at the moment, with a recommendation rating of 2.2. None of the analysts rate the stock as a Sell, while none rate it as Overweight. 1 out of 4 have rated it as a Hold, with 3 advising it as a Buy. None have rated the stock as Underweight. The expected earnings per share for the stock is -$0.39.

Caladrius Biosciences, Inc. (NASDAQ:CLBS) trade information

Sporting 8.8% in the green today, the stock has traded in the green over the last five days, with the highest price hit on Tuesday, Jul 14 when the CLBS stock price touched $2.58-6 or saw a rise of 6%. Year-to-date, Caladrius Biosciences, Inc. shares have moved -3.38%, while the 5-day performance has seen it change 23.1%. Over the past 30 days, the shares of Caladrius Biosciences, Inc. (NASDAQ:CLBS) have changed 38.58%. Short interest in the company has seen 169.97 Million shares shorted with days to cover at 0.34.

Wall Street analysts have a consensus price target for the stock at $10.5, which means that the shares’ value could jump 346.81% from current levels. The projected low price target is $6 while the price target rests at a high of $18.5. In that case, then, we find that the current price level is +687.23% off the targeted high while a plunge would see the stock lose 155.32% from current levels.

Caladrius Biosciences, Inc. (CLBS) estimates and forecasts

If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was +35.5% over the past 5 years. Earnings growth for 2020 is a modest -12.4%.